237 related articles for article (PubMed ID: 35121941)
1. Downregulation of the FTO m
Jeschke J; Collignon E; Al Wardi C; Krayem M; Bizet M; Jia Y; Garaud S; Wimana Z; Calonne E; Hassabi B; Morandini R; Deplus R; Putmans P; Dube G; Singh NK; Koch A; Shostak K; Rizzotto L; Ross RL; Desmedt C; Bareche Y; Rothé F; Lehmann-Che J; Duterque-Coquillaud M; Leroy X; Menschaert G; Teixeira L; Guo M; Limbach PA; Close P; Chariot A; Leucci E; Ghanem G; Yuan BF; Willard-Gallo K; Sotiriou C; Marine JC; Fuks F
Nat Cancer; 2021 Jun; 2(6):611-628. PubMed ID: 35121941
[TBL] [Abstract][Full Text] [Related]
2. The m
Li X; Li Y; Wang Y; He X
Cytokine; 2022 Nov; 159():156000. PubMed ID: 36058192
[TBL] [Abstract][Full Text] [Related]
3. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
4. M
Lv D; Ding S; Zhong L; Tu J; Li H; Yao H; Zou Y; Zeng Z; Liao Y; Wan X; Wen L; Xie X
Oncogene; 2022 Mar; 41(12):1727-1741. PubMed ID: 35121825
[TBL] [Abstract][Full Text] [Related]
5. m
Wang W; He Y; Zhai LL; Chen LJ; Yao LC; Wu L; Tang ZG; Ning JZ
Epigenetics; 2022 Dec; 17(12):1738-1752. PubMed ID: 35404184
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
7. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation.
Ou B; Liu Y; Gao Z; Xu J; Yan Y; Li Y; Zhang J
Cell Death Dis; 2022 Oct; 13(10):905. PubMed ID: 36302751
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 Regulates N
Liu X; Liu J; Xiao W; Zeng Q; Bo H; Zhu Y; Gong L; He D; Xing X; Li R; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Guo F; Xu C; Chen X; Wang X; Wang F; Wang Q; Cao K
Hepatology; 2020 Dec; 72(6):2029-2050. PubMed ID: 32154934
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
[TBL] [Abstract][Full Text] [Related]
10. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
11. Chemical Inhibitors Targeting the Oncogenic m
Huang Y; Xia W; Dong Z; Yang CG
Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
[TBL] [Abstract][Full Text] [Related]
12. Rational Design and Optimization of m
Huff S; Kummetha IR; Zhang L; Wang L; Bray W; Yin J; Kelley V; Wang Y; Rana TM
J Med Chem; 2022 Aug; 65(16):10920-10937. PubMed ID: 35939803
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N
Zhou J; Zhu Y; Ai D; Zhou M; Li H; Li G; Zheng L; Song J
J Transl Med; 2023 Nov; 21(1):781. PubMed ID: 37925419
[TBL] [Abstract][Full Text] [Related]
15. GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability.
Zhou Y; Zhou X; Ben Q; Liu N; Wang J; Zhai Y; Bao Y; Zhou L
J Transl Med; 2023 Dec; 21(1):882. PubMed ID: 38057853
[TBL] [Abstract][Full Text] [Related]
16. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
Huang J; Yang J; Zhang Y; Lu D; Dai Y
Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
[TBL] [Abstract][Full Text] [Related]
17. FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells.
Zhao F; Ge F; Xie M; Li Z; Zang C; Kong L; Pu Y; Zheng X; Tan Y
Clin Exp Metastasis; 2022 Aug; 39(4):623-639. PubMed ID: 35524932
[TBL] [Abstract][Full Text] [Related]
18. FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt/β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT.
Wang T; Li W; Ye B; Zhang S; Lei X; Zhang D
J BUON; 2021; 26(4):1279-1291. PubMed ID: 34564982
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
20. Novel evidence for m
Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A
Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
